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Background: DNA repair deficiencies have been postulated to play a role in the development and progression of cardiovascular disease (CVD). 
The hypothesis is that DNA damage induces cell death that promotes formation of unstable plaques. Using a DNA repair pathway approach we 
systematically examined whether common genetic variation in DNA excision repair genes influenced the risk of cardiovascular events.
Methods: The DNA biobank from 5,244 subjects of the PROspective Study of Pravastatin in the Elderly at Risk (PROSPER) was studied. Cases were 
defined as patients with fatal/non-fatal myocardial infarction or stroke (N=1,714) and were compared to controls without events (N=3,530). DNA 
excision repair genes were selected using a systematic pathway approach. A total of 38 single nucleotide polymorphisms (SNPs) within 14 genes 
were selected. Genotyping was performed using Illumina Human 660-Quad Beadchips. Associations were tested with logistic regression and multi 
testing correction was applied.
Results: A polymorphism in the SMARCA2 gene (rs9298820) was associated with an increased risk of events, OR 1.14 (95% CI 1.05-1.25), 
p=0.002. Inspection of the genomic region of SMARCA2 revealed 6 independent loci associated with the endpoint, of which the strongest 
association was found with rs3793516, OR 1.18 (1.08-1.30), p=0.0002. A risk score of the 6 SNPs demonstrated a solid association with 
cardiovascular events, OR 1.13 (1.07-1.19), p= 9.0E-6.
Conclusions: In this explorative study we found an association of cardiovascular events and genetic variation in the SMARCA2 gene, a gene 
involved in chromatin remodelling. The fact that several loci within the gene were associated and the risk score showed a strong association, 
increases the likelihood of causal involvement of this gene. These hypotheses-generating findings require extension by replication and functional 
analysis.
